Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation strategies in critically ill COPD
NCT03678532Completed
- Sponsor
- Assiut University
- Start
- Jul 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of midazolam in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Assiut University. Primary endpoint: Partial Pressure of Carbon Dioxide at 48 hours. Started Jul 2016; status: completed.
02
Drugs
midazolam
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03678532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678532.